Adial Pharmaceuticals, Inc. Operating Lease, Liability, Noncurrent
Adial Pharmaceuticals, Inc. (ADIL) had Operating Lease, Liability, Noncurrent of $135.04 thousand as of 2023-03-31, per its 10-Q filed 2023-05-12.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2023-05-12
- 2023-03-31: Operating Lease, Liability, Noncurrent $135.04K.
- 2022-12-31: Operating Lease, Liability, Noncurrent $150.55K.
- 2022-09-30: Operating Lease, Liability, Noncurrent $165.29K.
- 2022-06-30: Operating Lease, Liability, Noncurrent $179.70K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2023-03-31 | $135.04K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $150.55K 10-Q · filed 2023-05-12 |
| 2022-09-30 | $165.29K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $179.70K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $193.80K 10-Q · filed 2022-05-16 |
| 2021-12-31 | $207.38K 10-K · filed 2023-03-30 |
| 2021-09-30 | $220.25K 10-Q · filed 2021-11-15 |
| 2021-06-30 | $227.19K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $239.50K 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |